Harold W. Horowitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Harold W. Horowitz has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Aaron Brandwein
New York Presbyterian Brooklyn Methodist Hospital , Brooklyn, NY, New York
1 shared publicationAllison Stilwell
NewYork-Presbyterian Brooklyn Methodist Hospital , Brooklyn, New York
1 shared publication- Anne Norris
NewYork-Presbyterian Hospital
1 shared publication Barbara Ross
NewYork-Presbyterian Hospital
1 shared publicationBella Kohn
Bellevue Hospital Center (BHC), New York, NY, USA
1 shared publication- Bobbi S. Pritt
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
1 shared publication
Latest Publications
- Open Access
- 27 October 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e353
A quality improvement project to reduce follow-up blood culture utilization through diagnostic stewardship
Objective: To reduce the use of follow-up blood cultures (FUBC), that is repeat blood cultures (BCs) used to monitor patients for clearance of a prior positive BC, or with new/worsening symptoms after negative BCs, by 10%. Design: Multicenter quality improvement study. Setting: A network of 8 hospitals, including academic tertiary care centers and community hospitals. Participants: 40,021 patients, including adult, pediatric, inpatients, and outpatients, for whom blood cultures were ordered over a 24-week period in 2024. Interventions: We implemented a series of iterative Plan-Do-Study-Act (PDSA) cycles to guide clinicians toward appropriate BC ordering. These cycles included educational memos, limiting the ability to order more than one BC at a time, a best practice advisory in the electronic health record to limit BC orders with a prior negative within 72 hours, and a new order panel for BCs that defaulted FUBC to a single set. Results: Prior to the intervention period, FUBCs comprised 29% of all BC orders placed. After the intervention, there was an 18% absolute reduction in FUBC, primarily due to decreased use of paired FUBC sets. There were no increases in the length of stay, in-hospital mortality, or 30-day readmission. Conclusions: We exceeded our goal to decrease FUBCs using diagnostic stewardship. This approach to FUBCs is sustainable and scalable as part of diagnostic stewardship strategies for BC stewardship.
- 27 October 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e353
Open AccessA quality improvement project to reduce follow-up blood culture utilization through diagnostic stewardship
Objective: To reduce the use of follow-up blood cultures (FUBC), that is repeat blood cultures (BCs) used to monitor patients for clearance of a prior positive BC, or with new/worsening symptoms after negative BCs, by 10%. Design: Multicenter quality improvement study. Setting: A network of 8 hospitals, including academic tertiary care centers and community hospitals. Participants: 40,021 patients, including adult, pediatric, inpatients, and outpatients, for whom blood cultures were ordered over a 24-week period in 2024. Interventions: We implemented a series of iterative Plan-Do-Study-Act (PDSA) cycles to guide clinicians toward appropriate BC ordering. These cycles included educational memos, limiting the ability to order more than one BC at a time, a best practice advisory in the electronic health record to limit BC orders with a prior negative within 72 hours, and a new order panel for BCs that defaulted FUBC to a single set. Results: Prior to the intervention period, FUBCs comprised 29% of all BC orders placed. After the intervention, there was an 18% absolute reduction in FUBC, primarily due to decreased use of paired FUBC sets. There were no increases in the length of stay, in-hospital mortality, or 30-day readmission. Conclusions: We exceeded our goal to decrease FUBCs using diagnostic stewardship. This approach to FUBCs is sustainable and scalable as part of diagnostic stewardship strategies for BC stewardship.
- Open Access
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
2267. Evaluation of Antibiotic Prescribing Trends from a Dental Clinic After Implementation of a Dental Antimicrobial Stewardship Initiative
Inappropriate antibiotic prescribing by dentists is as high as 80% and in the U.S., dentists rank third for writing the most antibiotic prescriptions. At NewYork-Presbyterian Brooklyn Methodist (NYP-BMH), the Antimicrobial Stewardship Program (ASP) and Division of Dental Medicine collaborated to create a clinical practice guideline regarding antibiotic use in dentistry that was implemented in May 2021 and is reinforced with annual education to dental prescribers. The purpose of this study is to compare outpatient antibiotic prescribing trends pre- and post-guideline implementation. Patients presenting to NYP-BMH dental clinic for an emergent indication and prescribed an antibiotic from January-April of 2019-2021 (pre) and January-April of 2022 (post) were included. The primary outcome was appropriateness of antibiotic therapy. Secondary outcomes included a comparison of antibiotic selection, dosing and duration of therapy. A subgroup analysis of patients with reported penicillin allergies was conducted to compare alternative agents prescribed. A total of 119 patients in the pre and 100 patients in the post-guideline period were included. The primary outcome of appropriate antibiotic prescriptions significantly improved after guideline implementation (pre 45% vs post 64%, p< 0.01). The majority of antibiotic indications were treatment-related and the most common dental diagnosis was caries. The most common antibiotic prescribed in the study was amoxicillin. Compared to pre-guideline, there was significant decreased utilization of penicillin VK (pre 3.4% vs post 0%, p=0.05) and amoxicillin-clavulanate post-guideline (pre 16% vs post 8%, p=0.02). A wide variety of dosing regimens were utilized with more guideline-concordant regimens utilized post-guideline (pre 59% vs post 72%, p=0.04). On average, shorter durations of therapy were prescribed post-guideline (pre 6.8 days vs post 5.7 days, p< 0.02). Penicillin-allergic patients were prescribed less clindamycin after guideline implementation. ASP initiatives and collaboration with outpatient dental clinics can improve appropriate antibiotic prescribing. As ASPs look to expand into ambulatory care settings, dental clinics should be prioritized. All Authors: No reported disclosures
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
Open Access2267. Evaluation of Antibiotic Prescribing Trends from a Dental Clinic After Implementation of a Dental Antimicrobial Stewardship Initiative
Inappropriate antibiotic prescribing by dentists is as high as 80% and in the U.S., dentists rank third for writing the most antibiotic prescriptions. At NewYork-Presbyterian Brooklyn Methodist (NYP-BMH), the Antimicrobial Stewardship Program (ASP) and Division of Dental Medicine collaborated to create a clinical practice guideline regarding antibiotic use in dentistry that was implemented in May 2021 and is reinforced with annual education to dental prescribers. The purpose of this study is to compare outpatient antibiotic prescribing trends pre- and post-guideline implementation. Patients presenting to NYP-BMH dental clinic for an emergent indication and prescribed an antibiotic from January-April of 2019-2021 (pre) and January-April of 2022 (post) were included. The primary outcome was appropriateness of antibiotic therapy. Secondary outcomes included a comparison of antibiotic selection, dosing and duration of therapy. A subgroup analysis of patients with reported penicillin allergies was conducted to compare alternative agents prescribed. A total of 119 patients in the pre and 100 patients in the post-guideline period were included. The primary outcome of appropriate antibiotic prescriptions significantly improved after guideline implementation (pre 45% vs post 64%, p< 0.01). The majority of antibiotic indications were treatment-related and the most common dental diagnosis was caries. The most common antibiotic prescribed in the study was amoxicillin. Compared to pre-guideline, there was significant decreased utilization of penicillin VK (pre 3.4% vs post 0%, p=0.05) and amoxicillin-clavulanate post-guideline (pre 16% vs post 8%, p=0.02). A wide variety of dosing regimens were utilized with more guideline-concordant regimens utilized post-guideline (pre 59% vs post 72%, p=0.04). On average, shorter durations of therapy were prescribed post-guideline (pre 6.8 days vs post 5.7 days, p< 0.02). Penicillin-allergic patients were prescribed less clindamycin after guideline implementation. ASP initiatives and collaboration with outpatient dental clinics can improve appropriate antibiotic prescribing. As ASPs look to expand into ambulatory care settings, dental clinics should be prioritized. All Authors: No reported disclosures
- 1 November 2021
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 12 (6) , 101823
Ehrlichiosis and anaplasmosis subcommittee report to the Tick-borne Disease Working Group
- 1 November 2021
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 12 (6) , 101823
Ehrlichiosis and anaplasmosis subcommittee report to the Tick-borne Disease Working Group
- 1 August 2021
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 27 (8) , 2235-2236
COVID-19 and the Consequences of Anchoring Bias
COVID-19 and the Consequences of Anchoring Bias
- 1 August 2021
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 27 (8) , 2235-2236
COVID-19 and the Consequences of Anchoring Bias
COVID-19 and the Consequences of Anchoring Bias
- 7 January 2021
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (2) , e523
Use of an Electronic Medical Record Alert
Harold Horowitz, M.D; Use of an electronic medical record alert, Clinical Infectious Diseases, , ciab009, https://doi.org/10.1093/cid/ciab009
- 7 January 2021
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (2) , e523
Use of an Electronic Medical Record Alert
Harold Horowitz, M.D; Use of an electronic medical record alert, Clinical Infectious Diseases, , ciab009, https://doi.org/10.1093/cid/ciab009
- 1 August 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (3) , 481-482
Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential?
To the Editor—The letter from Musher et al [1] regarding the evolving role of Streptococcus pneumoniae as a cause of pneumonia in adults raises a question regarding the treatment of community-acquired pneumonia (CAP) that deserves attention. In their review of data reporting the causes of CAP since 2010 in the United States, there is a remarkably low incidence of Legionella, Mycoplasma, and Chlamydia causing CAP (1%–2% total reported from 3 separate studies [1], table 3). The percentage of pneumonias due to these “atypical” organisms in the United States is markedly lower than in prior years as well as lower than that...
- 1 August 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (3) , 481-482
Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential?
To the Editor—The letter from Musher et al [1] regarding the evolving role of Streptococcus pneumoniae as a cause of pneumonia in adults raises a question regarding the treatment of community-acquired pneumonia (CAP) that deserves attention. In their review of data reporting the causes of CAP since 2010 in the United States, there is a remarkably low incidence of Legionella, Mycoplasma, and Chlamydia causing CAP (1%–2% total reported from 3 separate studies [1], table 3). The percentage of pneumonias due to these “atypical” organisms in the United States is markedly lower than in prior years as well as lower than that...
- 1 July 2018
- Published by Elsevier in American Journal of Infection Control
- Vol. 46 (7) , 734-735
Infection control IV: Moving forward- infection preventionists' scope of practice
- 1 July 2018
- Published by Elsevier in American Journal of Infection Control
- Vol. 46 (7) , 734-735
Infection control IV: Moving forward- infection preventionists' scope of practice
- 7 September 2017
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 31 (5) , 450-456
To Assess the Success of Computerized Order Sets and Pharmacy Education Modules in Improving Antiretroviral Prescribing
To assess the success of order set and pharmacist training improvement (OSPTI) in improving prescription of antiretroviral therapy (ART) in a tertiary care, public, teaching hospital. In this pre-OSPTI (January 2012 through June 2013) and post-OSPTI study (July 2013 through September 2014), an infectious disease pharmacist reviewed all patients on ART. A review of intervention data in July 2013 led to order-set changes in the hospital’s computerized order entry system for frequently intervened on antiretrovirals: ritonavir, tenofovir, emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), and lamivudine. Concurrently, case-based education modules were conducted to help pharmacists identify ART errors. The number of patients on ART, number of interventions, and types of ritonavir interventions were compared between pre- and post-OSPTI periods. In the pre-OSPTI period, an average of 239 patients were reviewed per quarter compared to an average of 216 per quarter in the post-OSPTI period. After implementing enhanced order sets, the number of interventions decreased by approximately 34% (P < .0001). The number of ritonavir interventions decreased on average by 45% (P < .0001), although the types of ritonavir interventions were similar. Enhanced antiretroviral order sets and pharmacy education modules improved ART prescription by reducing the overall number of antiretroviral interventions required per quarter. This modality was effective in improving prescribing of ART and reducing the need for pharmacist interventions.
- 7 September 2017
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 31 (5) , 450-456
To Assess the Success of Computerized Order Sets and Pharmacy Education Modules in Improving Antiretroviral Prescribing
To assess the success of order set and pharmacist training improvement (OSPTI) in improving prescription of antiretroviral therapy (ART) in a tertiary care, public, teaching hospital. In this pre-OSPTI (January 2012 through June 2013) and post-OSPTI study (July 2013 through September 2014), an infectious disease pharmacist reviewed all patients on ART. A review of intervention data in July 2013 led to order-set changes in the hospital’s computerized order entry system for frequently intervened on antiretrovirals: ritonavir, tenofovir, emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), and lamivudine. Concurrently, case-based education modules were conducted to help pharmacists identify ART errors. The number of patients on ART, number of interventions, and types of ritonavir interventions were compared between pre- and post-OSPTI periods. In the pre-OSPTI period, an average of 239 patients were reviewed per quarter compared to an average of 216 per quarter in the post-OSPTI period. After implementing enhanced order sets, the number of interventions decreased by approximately 34% (P < .0001). The number of ritonavir interventions decreased on average by 45% (P < .0001), although the types of ritonavir interventions were similar. Enhanced antiretroviral order sets and pharmacy education modules improved ART prescription by reducing the overall number of antiretroviral interventions required per quarter. This modality was effective in improving prescribing of ART and reducing the need for pharmacist interventions.
- 1 May 2017
- Published by Elsevier in American Journal of Infection Control
- Vol. 45 (5) , 519-520
Infection control III: Infection prevention and control as mediators
- 1 May 2017
- Published by Elsevier in American Journal of Infection Control
- Vol. 45 (5) , 519-520
Infection control III: Infection prevention and control as mediators